HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Muñoz Selected Research

C Muñoz Research Topics

Disease

4Psoriasis (Pustulosis Palmaris et Plantaris)
12/2020 - 09/2013
4Neoplasms (Cancer)
05/2020 - 04/2002
4Infections
01/2019 - 11/2000
3Hypersensitivity (Allergy)
09/2018 - 03/2014
3Fibrosis (Cirrhosis)
11/2007 - 06/2004
2Hematoma
04/2021 - 11/2000
2Insulin Resistance
12/2018 - 01/2010
2Obesity
12/2018 - 02/2016
2Colonic Neoplasms (Colon Cancer)
09/2018 - 04/2002
2Alzheimer Disease (Alzheimer's Disease)
01/2018 - 08/2004
2Ulcerative Colitis
01/2018 - 11/2017
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2017 - 09/2011
2Cognitive Dysfunction
01/2009 - 06/2008
2Ascites
11/2007 - 06/2004
2Chronic Hepatitis C
07/2006 - 07/2005
1Vocal Cord Paralysis
04/2021
1Surgical Wound
04/2021
1Paralysis (Palsy)
04/2021
1Recurrent Laryngeal Nerve Injuries
04/2021
1Febrile Neutropenia
05/2020
1Hypertension (High Blood Pressure)
01/2020
1Cardiovascular Diseases (Cardiovascular Disease)
01/2020
1Cardiomegaly (Heart Hypertrophy)
01/2020
1Edema (Dropsy)
01/2020
1Leishmaniasis
01/2019
1Egg Hypersensitivity (Egg Allergy)
09/2018
1Dentofacial Deformities
05/2018
1Carcinoma (Carcinomatosis)
01/2018
1Disease Progression
01/2018
1Crohn Disease (Crohn's Disease)
01/2017
1Psoriatic Arthritis
09/2014
1Cutaneous Leishmaniasis
09/2014
1Fever (Fevers)
03/2014
1Papillomavirus Infections
02/2014
1Testicular Germ Cell Tumor
02/2014

Drug/Important Bio-Agent (IBA)

3AntibodiesIBA
01/2019 - 07/2002
3Infliximab (Remicade)FDA Link
01/2017 - 09/2013
3AnticoagulantsIBA
11/2013 - 11/2000
3Bacterial DNAIBA
11/2007 - 06/2004
3CytokinesIBA
07/2006 - 05/2003
3RNA (Ribonucleic Acid)IBA
01/2003 - 09/2001
2Pharmaceutical PreparationsIBA
12/2020 - 11/2013
2C-Reactive ProteinIBA
12/2018 - 01/2010
2Toll-Like Receptors (Toll-Like Receptor)IBA
03/2018 - 01/2018
2SteroidsIBA
01/2018 - 11/2017
2Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2017 - 09/2013
2Adalimumab (Humira)FDA Link
01/2017 - 09/2013
2MelatoninIBA
09/2009 - 08/2001
2Neuroprotective AgentsIBA
09/2009 - 05/2003
2AntigensIBA
03/2008 - 02/2001
2Immunoglobulin M (IgM)IBA
03/2008 - 07/2002
2Ribavirin (Virazole)FDA LinkGeneric
07/2006 - 07/2005
1Mepivacaine (Carbocaine)FDA LinkGeneric
04/2021
1Local AnestheticsIBA
04/2021
1apremilastIBA
12/2020
1Meropenem (Merrem)FDA LinkGeneric
05/2020
1LactamsIBA
05/2020
1Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
05/2020
1Cefepime (Maxipime)FDA LinkGeneric
05/2020
1Anti-Bacterial Agents (Antibiotics)IBA
05/2020
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
01/2020
1Fibrinogen (Factor I)FDA Link
01/2020
1InsecticidesIBA
01/2019
1imidaclopridIBA
01/2019
1Permethrin (Ambush)FDA LinkGeneric
01/2019
1Glucagon-Like Peptide-1 ReceptorIBA
12/2018
1Blood Glucose (Blood Sugar)IBA
12/2018
1Insulin (Novolin)FDA Link
12/2018
1LipidsIBA
12/2018
1LuciferasesIBA
09/2018
1Egg ProteinsIBA
09/2018
1MicroRNAs (MicroRNA)IBA
09/2018
1crenezumabIBA
01/2018
1Amyloid (Amyloid Fibrils)IBA
01/2018
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017
1Immunologic Factors (Immunomodulators)IBA
01/2017
1Immunoglobulin E (IgE)IBA
03/2016
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
02/2016
1MeglumineFDA Link
09/2014
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
03/2014
1EtoricoxibIBA
03/2014
1Meloxicam (Mobic)FDA LinkGeneric
03/2014
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
03/2014
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
03/2014
1VaccinesIBA
02/2014
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
02/2014
1Cisplatin (Platino)FDA LinkGeneric
02/2014
1Heparin (Liquaemin)FDA LinkGeneric
11/2013
1Fondaparinux (Arixtra)FDA Link
11/2013

Therapy/Procedure

6Therapeutics
05/2020 - 11/2000
1Parathyroidectomy
04/2021
1Drug Therapy (Chemotherapy)
05/2020
1Immunotherapy
09/2018
1Genioplasty
05/2018
1Cholecystectomy
01/2018
1Colectomy
01/2018
1Lymph Node Excision (Lymph Node Dissection)
01/2018
1Retreatment
01/2017
1Cryotherapy (Therapy, Cold)
09/2014
1Heart-Assist Devices
11/2013